BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter study-Reference-Cited by-同舟云学术

BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter study

Published:2023-12 Issue:12 Volume:41 Page:484.e17-484.e26
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Ecke Thorsten H.^ORCID,Meisl Christina J.,Schlomm Thorsten,Rabien Anja,Labonté Flora,Rong Dezhi,Hofbauer Sebastian,Friedersdorff Frank,Sommerfeldt Lilli,Gagel Nella,Gössl Andreas,Barski Dimitri,Otto Thomas,Grunewald Camilla M.,Niegisch Günter,Hennig Martin J.P.,Kramer Mario W.,Koch Stefan,Roggisch Jenny,Hallmann Steffen,Weiß Sarah,Waldner Michael,Graff Johannes,Veltrup Elke,Linden Friederike,Hake Roland,Eidt Sebastian,Wirtz Ralph M.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference32 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021

3. Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO/ICUD consensus;Schmitz-Dräger;Urol Int,2015

4. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses;Lotan;Urology,2003

5. Sensitivity of human complement factor H related protein (BTA stat) test and voided urine cytology in the diagnosis of bladder cancer;Raitanen;J Urol,2000

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The UF-5000 Atyp.C parameter is an independent risk factor for bladder cancer;Scientific Reports;2024-06-03

2. Urine-Based Biomarker Test Uromonitor® in the Detection and Disease Monitoring of Non-Muscle-Invasive Bladder Cancer—A Systematic Review and Meta-Analysis of Diagnostic Test Performance;Cancers;2024-02-11